A federal appeals court on Wednesday ruled that Nasdaq could not impose rules requiring companies listed on the exchange to havewomen and minority directors on their boardsor explain why they do not.
The New Orleans-based 5th US Circuit Court of Appeals on a 9-8 vote sided with two conservative advocacy groups in finding that the rules approved by the Securities and Exchange Commission ran afoul of federal securities law.
Nasdaq sought to impose rules requiring companies listed on the exchange to have women and minority directors on their boards. CEO Adena Friedman, above.Getty Images for Fortune Media Those rules were challenged by the National Center for Public Policy Research, a conservative think tank, and Alliance for Fair Board Recruitment, a group founded byaffirmative action opponent Edward Blum.
A three-judge panel of the 5th Circuit comprised entirely of appointees of Democratic presidents in October 2023 upheld the SEC’s 2021 decision to approve Nasdaq’s rules, saying the regulator acted within its authority.
But the full conservative-majority court opted to reconsider the matter. All nine judges in the majority were appointed by Republican presidents, including the ruling’s author, US Circuit Judge Andrew Oldham, who was appointed by President-elect Donald Trump in his first term.
The problem is that temporarily pausing drug use can lead to weight gain, mood changes and digestive issues, among other potential short- and long-term side effects.
A recent KFF Health Tracking Poll found 12% of adults have taken an Ozempic-like drug at some point and 6% were taking one as of May.alones – stock.adobe.com
An overwhelming 79% of people who said they plan to skip jabs over the holidays admitted that it’s so they can enjoy more holiday foods.
Half said they wanted to avoid the side effects of eating rich foods on GLP-1 drugs — which can include fullness, nausea, and other gastrointestinal discomfort — while 28% said they wanted to take a break from their daily routines.
Less than a quarter said it was due to medication costs or concerns about interactions with alcohol.
While skipping a dose or two may allow for more room to indulge, it can also lead to some unwanted complications.
“Taking a break from weight-loss medication over the holidays might seem like a small decision, but it can have lasting effects,” explained Dr. Catherine Hyatt, medical content lead at Levity, an online weight-loss management service that conducted the new poll of 1,000 US and UK residents.
“Many people experience weight gain, and an increase in cravings when they stop suddenly. This can lead to a frustrating cycle of losing and regaining weight,” Hyatt continued. “That’s why planning ahead and getting advice from a health care professional is so important.”
People who are skipping doses say it’s mostly to enjoy more food.Levity A recent KFF Health Tracking Poll revealed that 12% of US adults have taken an Ozempic-like drug at some point and 6% were using one as of May.
These medications suppress appetite and spur weight loss by mimicking GLP-1, the hormone the body naturally produces after eating, so users feel fuller for longer.
About 24% of those surveyed by Levity anticipate gaining more than 5 pounds over the holidays because they deserted their weekly jab — and 63% of those planning to take a holiday break admit they haven’t consulted with their doctor.
A recent report found that most people taking GLP-1 drugs do not stay on their prescribed treatment for a minimum of 12 weeks. More than 30% of patients drop it after just four weeks because they suffer early side effects like nausea or other digestive problems — or they can’t afford to continue.
In the Levity survey, 42% of US GLP-1 users confessed to skipping their medication during social events like vacations and restaurant meals with friends and family.
The Levity survey of 1,000 US and UK users of drugs like Ozempic revealed why many are planning to skip their injections for the holidays.Levity Nearly one in three Americans (32%) have struggled to resume their GLP-1 routine, with men reporting more difficulties than women.
“If you’ve taken a break from weight-loss medication, it’s important to ease back into it carefully,” Hyatt said.
“Work with your doctor to create a plan that gradually reintroduces the treatment, minimizing any side effects,” she added. “Eating well-balanced meals and getting some regular exercise can also make the process smoother and help you stay on track.”
